Source:http://linkedlifedata.com/resource/pubmed/id/16894115
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-8-8
|
pubmed:abstractText |
The authors studied seven patients with mitochondrial DNA (mtDNA) myopathy. Over time, there was a progressive depletion of mtDNA, which preferentially affected wild-type mitochondrial genomes. This suggests that loss of wild-type mtDNA is a major feature of mtDNA myopathy, and preventing wild-type mtDNA depletion has treatment implications.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1526-632X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
8
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
502-4
|
pubmed:dateRevised |
2011-1-5
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Progressive depletion of mtDNA in mitochondrial myopathy.
|
pubmed:affiliation |
Mitochondrial Research Group, Neurology, University of Newcastle upon Tyne, Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|